US6610271B2
(en)
*
|
2000-05-10 |
2003-08-26 |
University Of Kentucky Research Foundation |
System and method for intranasal administration of lorazepam
|
US20060083691A1
(en)
*
|
2000-05-10 |
2006-04-20 |
Wermeling Daniel P |
Intranasal opioid compositions, delivery devices and methods of using same
|
US20040115133A1
(en)
|
2000-05-10 |
2004-06-17 |
Wermeling Daniel P. |
Intranasal opioid compositions
|
JP4898073B2
(en)
|
2000-07-31 |
2012-03-14 |
ニュコメデ ダンマルク アンパーツセルスカブ |
Fentanyl composition for intranasal administration
|
AU2001286518A1
(en)
|
2000-08-15 |
2002-02-25 |
University Of Kentucky Research Foundation |
Programmable multi-dose intranasal drug delivery device
|
US20040176359A1
(en)
*
|
2001-02-20 |
2004-09-09 |
University Of Kentucky Research Foundation |
Intranasal Benzodiazepine compositions
|
US7666876B2
(en)
*
|
2002-03-19 |
2010-02-23 |
Vernalis (R&D) Limited |
Buprenorphine formulations for intranasal delivery
|
CN1674903A
(en)
*
|
2002-07-11 |
2005-09-28 |
大鹏药品工业株式会社 |
Composition for transnasal absorption
|
GB0300531D0
(en)
|
2003-01-10 |
2003-02-12 |
West Pharm Serv Drug Res Ltd |
Pharmaceutical compositions
|
AU2004218876B2
(en)
*
|
2003-03-11 |
2007-08-02 |
Arakis Ltd. |
Novel compositions containing fentanyl
|
US20050175679A1
(en)
*
|
2004-02-10 |
2005-08-11 |
Michael Moshman |
Controlled release formulations
|
JP5276982B2
(en)
|
2005-08-26 |
2013-08-28 |
ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ |
Method for the treatment of headache by administration of oxytocin
|
US8357114B2
(en)
|
2006-01-06 |
2013-01-22 |
Acelrx Pharmaceuticals, Inc. |
Drug dispensing device with flexible push rod
|
US9289583B2
(en)
|
2006-01-06 |
2016-03-22 |
Acelrx Pharmaceuticals, Inc. |
Methods for administering small volume oral transmucosal dosage forms using a dispensing device
|
US8252328B2
(en)
*
|
2006-01-06 |
2012-08-28 |
Acelrx Pharmaceuticals, Inc. |
Bioadhesive drug formulations for oral transmucosal delivery
|
US9066847B2
(en)
|
2007-01-05 |
2015-06-30 |
Aceirx Pharmaceuticals, Inc. |
Storage and dispensing devices for administration of oral transmucosal dosage forms
|
US8535714B2
(en)
|
2006-01-06 |
2013-09-17 |
Acelrx Pharmaceuticals, Inc. |
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
|
US8865743B2
(en)
|
2006-01-06 |
2014-10-21 |
Acelrx Pharmaceuticals, Inc. |
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
|
US8202535B2
(en)
*
|
2006-01-06 |
2012-06-19 |
Acelrx Pharmaceuticals, Inc. |
Small-volume oral transmucosal dosage forms
|
US8252329B2
(en)
|
2007-01-05 |
2012-08-28 |
Acelrx Pharmaceuticals, Inc. |
Bioadhesive drug formulations for oral transmucosal delivery
|
US8753308B2
(en)
|
2006-01-06 |
2014-06-17 |
Acelrx Pharmaceuticals, Inc. |
Methods for administering small volume oral transmucosal dosage forms using a dispensing device
|
GB2437488A
(en)
*
|
2006-04-25 |
2007-10-31 |
Optinose As |
Pharmaceutical oily formulation for nasal or buccal administration
|
US20080275030A1
(en)
|
2007-01-19 |
2008-11-06 |
Sveinbjorn Gizurarson |
Methods and Compositions for the Delivery of a Therapeutic Agent
|
US9026369B2
(en)
|
2008-04-24 |
2015-05-05 |
The Invention Science Fund I, Llc |
Methods and systems for presenting a combination treatment
|
US9282927B2
(en)
|
2008-04-24 |
2016-03-15 |
Invention Science Fund I, Llc |
Methods and systems for modifying bioactive agent use
|
US9449150B2
(en)
|
2008-04-24 |
2016-09-20 |
The Invention Science Fund I, Llc |
Combination treatment selection methods and systems
|
US9239906B2
(en)
|
2008-04-24 |
2016-01-19 |
The Invention Science Fund I, Llc |
Combination treatment selection methods and systems
|
US9560967B2
(en)
|
2008-04-24 |
2017-02-07 |
The Invention Science Fund I Llc |
Systems and apparatus for measuring a bioactive agent effect
|
US9649469B2
(en)
|
2008-04-24 |
2017-05-16 |
The Invention Science Fund I Llc |
Methods and systems for presenting a combination treatment
|
US9064036B2
(en)
|
2008-04-24 |
2015-06-23 |
The Invention Science Fund I, Llc |
Methods and systems for monitoring bioactive agent use
|
US9662391B2
(en)
|
2008-04-24 |
2017-05-30 |
The Invention Science Fund I Llc |
Side effect ameliorating combination therapeutic products and systems
|
WO2010005400A1
(en)
*
|
2008-07-11 |
2010-01-14 |
Ix Biopharma Pte Ltd |
Opioid agonist compositions for pain management
|
US8945592B2
(en)
|
2008-11-21 |
2015-02-03 |
Acelrx Pharmaceuticals, Inc. |
Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
|
WO2010107761A1
(en)
|
2009-03-18 |
2010-09-23 |
Acelrx Pharmaceuticals, Inc. |
Improved storage and dispensing devices for administration of oral transmucosal dosage forms
|
EP2774935B8
(en)
|
2009-10-30 |
2017-06-21 |
NTF Therapeutics, Inc. |
Improved neurturin molecules
|
IT1400067B1
(en)
*
|
2010-05-21 |
2013-05-17 |
Molteni & C |
LIQUID NASAL SPRAY CONTAINING NALTREXONE WITH LOW DOSAGE.
|
US8627816B2
(en)
|
2011-02-28 |
2014-01-14 |
Intelliject, Inc. |
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
|
US8939943B2
(en)
|
2011-01-26 |
2015-01-27 |
Kaleo, Inc. |
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
|
ME02958B
(en)
|
2011-05-13 |
2018-07-20 |
Euro Celtique Sa |
Intranasal pharmaceutical dosage forms comprising naloxone
|
WO2015095644A1
(en)
|
2013-12-20 |
2015-06-25 |
AntiOP, Inc. |
Intranasal naloxone compositions and methods of making and using same
|
EP3777838A1
(en)
|
2014-03-14 |
2021-02-17 |
Opiant Pharmaceuticals, Inc. |
Nasal drug products and methods of their use
|
US9480644B2
(en)
|
2014-03-14 |
2016-11-01 |
Opiant Pharmaceuticals, Inc. |
Nasal drug products and methods of their use
|
US9561177B2
(en)
|
2014-03-14 |
2017-02-07 |
Adapt Pharma Limited |
Nasal drug products and methods of their use
|
US10085937B2
(en)
|
2014-03-14 |
2018-10-02 |
Adapt Pharma Limited |
Nasal drug products and methods of their use
|
WO2016007729A1
(en)
*
|
2014-07-09 |
2016-01-14 |
Lightlake Therapeutics Inc. |
Co-packaged drug products
|
US9517307B2
(en)
|
2014-07-18 |
2016-12-13 |
Kaleo, Inc. |
Devices and methods for delivering opioid antagonists including formulations for naloxone
|
AU2015369710B2
(en)
|
2014-12-23 |
2020-09-17 |
Vertical Pharmaceuticals, Llc |
Systems, devices and methods for dispensing oral transmucosal dosage forms
|
PT3242676T
(en)
|
2015-01-07 |
2023-12-06 |
TONIX Pharmaceuticals Holding Corp |
Magnesium-containing oxytocin formulations and methods of use
|
FR3032353B1
(en)
|
2015-02-06 |
2017-03-10 |
Jacques Seguin |
PHARMACEUTICAL COMPOSITION AND DEVICE FOR THE TREATMENT OF PAIN
|
US10512592B1
(en)
*
|
2017-10-13 |
2019-12-24 |
Amanpreet Sandhu |
Medication dispenser
|
US11862303B1
(en)
|
2018-04-19 |
2024-01-02 |
Telemedicine Health, Inc. |
Collection of digital health hubs with artificial intelligence
|
US11854680B1
(en)
|
2018-08-08 |
2023-12-26 |
Telemedicine Health, Inc. |
Narcotics and opioids secure storage and dispensing apparatus and method of use
|
US11311460B1
(en)
|
2018-08-08 |
2022-04-26 |
Telemedicine Health, Inc. |
Method and apparatus of secure storage for dispensing of opioids (SSDO)
|